and procedural understandings...http://www.asx.com.au/asxpdf/20090113/pdf/31fk0qqhwp5qc3.pdfrelease from 13/1... note the wording.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling